JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, A. J.
Right arrow Articles by Reller, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, A. J.
Right arrow Articles by Reller, L. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Jan 1995, 161-165, Vol 33, No. 1
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Clinical impact of bacteria and fungi recovered only from broth cultures

AJ Morris, SJ Wilson, CE Marx, ML Wilson, S Mirrett and LB Reller
Clinical Microbiology Laboratory, Duke University Medical Center, Durham, North Carolina 27710.

We prospectively evaluated 356 bacteria and fungi recovered from broth enrichment tubes from cultures with sterile direct plates to determine the clinical impact of isolates recovered only from broth cultures. These "broth only" isolates (BOI) were classified as contaminants or true on the basis of review of patient charts. True isolates were considered clinically relevant only if they altered or should have altered patient management. Of 356 BOI, 259 (73%) were considered contaminants (mostly coagulase-negative staphylococci and Propionibacterium spp.) and 97 (27%) were considered true. For individual microorganisms, 9 of 9 (100%) Staphylococcus aureus isolates, 13 of 13 (100%) members of the family Enterobacteriaceae, 10 of 12 (83%) fungi, 7 of 10 (70%) enterococci, 7 of 11 (64%) other gram- negative bacilli, 13 of 31 (45%) anaerobic bacteria, 10 of 24 (42%) streptococci, 22 of 140 (16%) coagulase-negative staphylococci, 6 of 92 (7%) Propionibacterium spp., and 0 of 14 (0%) diphtheroids and Bacillus spp. were classified as true. Eleven of 97 (11%) patients with true BOI had clinically relevant isolates. Fifty-nine of the 97 (61%) patients with true isolates already were on therapy, and no change was made because of the BOI. Six (6%) patients with contaminants received therapy for their BOI. We conclude that broth inoculated as an adjunct to direct plating seldom yields results that favorably alter patient management and could be omitted for most specimens without compromising patient care.


This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1995 by the American Society for Microbiology. All rights reserved.